Figures & data
Table I. Chlamydia trachomatis revisited: Major discoveries.
Table II. Meta-analysis of longitudinal studies on Chlamydia trachomatis infection and cervical neoplasia (Citation43).
Table III. Treatment for Chlamydia trachomatis: current recommendations.
Lyytikäinen E, Kaasila M, Koskela P, Lehtinen M, Patama T, Pukkala E, . Chlamydia trachomatis seroprevalence atlas of Finland 1983–2003. Sex Transm Infect. 2008; 84: 19–22. Lehtinen M, Lyytikäinen E, Koskela P, Surcel H-M, Paavonen J. Chlamydia trachomatis and risk for cervical neoplasia—a meta-analysis of longitudinal studies. Proceedings of the Twelfth International Symposium on Human Chlamydial Infections, International Chlamydia Symposium, Salzburg, Austria, 20–25 June 2010. Abstract. 445–8. Anttila T, Saikku P, Koskela P, Bloigu A, Dillner J, Ikäheimo I, . Serotypes of Chlamydia trachomatis and risk for cervical squamous cell carcinoma. JAMA. 2001;285: 47–51. Arnheim L. Immunological responses in genital HPV infections and etiology of cervical cancer. Thesis. Stockholm: Karolinska Institute; 2005. Lehtinen M, Dillner J, Knekt P, Luostarinen T, Aromaa A, Kirnbauer R, . Serologically diagnosed infection with human papillomavirus type 16 and risk for subsequent development of cervical carcinoma: nested case-control study. BMJ. 1996;312:537–9. Naucler P, Chen H-C, Persson K, You SL, Hsieh CY, Sun CA, . Seroprevalence of human papillomavirus and Chlamydia trachomatis and cervical cancer risk: nested case-control study. J Gen Virol. 2007;88:814–22. Koutsky LA, Holmes KK, Critchlow CW, Stevens CE, Paavonen J, Beckmann AM, . A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection. N Engl J Med. 1992;327:1272–8. Lehtinen M, Ault K, Lyytikäinen E, Dillner J, Garland SM, Ferris DG, . Chlamydia trachomatis infection and risk of cervical intraepithelial neoplasia. Sex Transm Infect. In press. Samoff E, Koumans EH, Markowitz LE, Sternberg M, Sawyer MK, Swan D, . Association of Chlamydia trachomatis with persistence of high-risk of human papillomavirus in a cohort of female adolescents. Am J Epidemiol. 2005;162:668–75. Silins I, Ryd W, Strand A, Törnberg S, Hansson BG, Wang X, . Chlamydia trachomatis infection and persistence of human papillomavirus. Int J Cancer. 2005;116:110–5. Kalwij S, Macintosh M, Baraitser P. Screening and treatment of Chlamydia trachomatis infections. BMJ. 2010;340:912–7.